Biotech | September 29, 2025
DINAMIQS inaugurates new cGMP viral vector manufacturing facility in Switzerland
The new site enables end-to-end production of viral vector gene therapies
The new site enables end-to-end production of viral vector gene therapies
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
The lab will facilitate the development of herbal and natural-based solutions
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated
